Abacavir/lamivudine

 
0.0 (0)
This page displays reviews written by users of all forms of Abacavir/lamivudine. You can also choose to see reviews only for a specific medical condition or brand name.

More about Abacavir/lamivudine

What is/are Abacavir/lamivudine?

Abacavir/lamivudine (INNs) is a combination drug for the treatment of HIV infection. It is marketed as Kivexa in most countries except for the United States, where it is branded as Epzicom. It is a fixed dose combination of lamivudine (3TC, Epivir) and abacavir (ABC, Ziagen). Lamivudine and abacavir are both nucleoside reverse transcriptase inhibitors (NRTI). It was approved by the FDA on August 2, 2004. It is marketed by ViiV Healthcare.

This article uses material from the Wikipedia article Abacavir/lamivudine, which is released under the Creative Commons Attribution-Share-Alike License 3.0.

Reviews for Abacavir/lamivudine

See reviews for a different combination of brand names and medical conditions:
     
There are no user reviews for this listing.
Already have an account?
Ratings
Overall satisfaction
Efficacy
Lack of side effects
Relevant Brand Name and Medical Condition
Additional Information
Please tell us about your experience with this medicine